Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-8sv2kpPhase 2Not yet recruiting
Phase 2, single-arm trial of cefixime in syphilis, sponsored by Universidade de Fortaleza. Planned start Apr 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-8sv2kp.